Q: James Cullem, how has past experience informed your knowledge of intellectual property (IP) activities?
James Cullem: Having been an entrepreneur, executive, and general counsel at early-stage biotechnology companies, I’ve learned that it’s vitally important to understand how to effectively and efficiently develop, manage, and leverage IP assets and strategy to increase competitive advantage and ensure growth.
Q: Why is intellectual property such a crucial element in start-up companies?
James Cullem: Intellectual property is an important asset at most start-up companies, and this is definitely true in the life science field. IP strategy and activities flow from the overall core vision and mission of the company, and must align with, and complement, overall business strategy. An intelligent and well-executed IP strategy and best practices in managing IP assets will underpin competitive advantage.